University of California San Francisco
Give to UCSF
Built on a foundation of scientific thinking, and one that exposes students to the latest questions in research and patient care, the School of Pharmacy’s new curriculum differentiates UCSF’s PharmD degree program from the growing number of programs nationwide.
For the first time, a drug derived from marijuana has been approved by the Food and Drug Administration, and it may soon offer relief to children with hard-to-treat seizures.
Sensory Processing Disorder, or SPD, causes some children to find everyday stimuli excruciating. Scientists are finally shedding light on what causes the disorder and what can be done about it.
The journey from discovering and developing effective, precise medications to using them correctly and safely in patients is hardly fast and easy. Nor is it a straight shot. Scientists in the UCSF School of Pharmacy are challenging the status quo every step of the way.
A UCSF researcher is among scientists who discovered the specific bacterial enzyme found in the human gut that can render a common heart drug ineffective.
Study led by UCSF scientists shows that brain cells react differently to opioid substances created inside the body than they do to purely synthetic opioid drugs.
UC San Francisco researchers have discovered a promising new line of attack against lethal, treatment-resistant prostate cancer.
Kathy Giacomini, PhD, has been named the 2018 Volwiler Research Achievement Award recipient by the American Association of Colleges of Pharmacy (AACP).
The use of newer blood-thinners for patients at risk of stroke may lead to two fewer days in the hospital for those who experience complications, with the same survival rate as the older drug warfarin.
The largest-ever whole-genome sequencing study of drug response in minority children has revealed new clues about why the front-line asthma drug albuterol does not work as well for minority children.
Researchers at UCSF have found a way to attack one of the most common drivers of lung, colorectal, and pancreatic cancer by targeting the proteins it produces on the outside of the cell.
Huang highlighted the microscopy work in his lab that has enabled a clearer understanding of the function of cells and the processes that underlie disease.
